FOR BIOTECH INVESTORS
Track catalysts before they move the stock
PDUFA dates, Phase 3 readouts, and pipeline changesβall in one place. Never miss another FDA decision.
Sound familiar?
"Another biotech popped 40% on an FDA approval you didn't see coming. The PDUFA date was buried in a 10-K you didn't have time to read."
The Problem
- PDUFA dates scattered across SEC filings
- Phase 3 readouts announced without warning
- No central calendar for biotech catalysts
- Miss opportunities or get blindsided
With TheraRadar
- All PDUFA dates in one calendar
- Phase 3 completion tracking
- Filter by date range and therapeutic area
- Watchlist alerts for your holdings
Catalysts We Track
PDUFA Dates
FDA decision deadlines for pending applications
Phase 3 Readouts
Expected completion dates for pivotal trials
AdCom Meetings
FDA advisory committee review dates
New Approvals
Recent FDA approvals and indication expansions
Investor Use Cases
The research you do before every position
Find Upcoming Catalysts
"What PDUFA dates are coming in the next 90 days?"
Assess Pipeline Depth
"How many Phase 3 assets does this company have?"
Evaluate Target Crowding
"Is KRAS too competitive to invest in?"
Track Indication Expansion
"What new indications is Keytruda pursuing?"
Built for Investors
PDUFA Calendar
All upcoming FDA decision dates in one view
Target Crowding
See how many competitors are in each mechanism
Pipeline by Phase
Company pipelines broken down by development stage
Watchlist Alerts
Get notified when your holdings have catalysts
Never miss another catalyst
Start with our free PDUFA calendar. No signup required.
View PDUFA Calendar